Course Description: Accumulating evidence indicates important gender differences in substance use disorders. Little is known, however, about gender differences and opioid use disorders.
Methods—Participants were 892 adults screened for the National Institute on Drug Abuse’s (NIDA) Clinical Trials Network (CTN) investigation of the effectiveness of two buprenorphine tapering schedules.
Conclusions—Important gender differences in the clinical profiles of opioid-dependent individuals were observed with regard to substance use severity, craving, medical conditions, and impairment in associated areas of functioning. The findings enhance understanding of the characteristics of treatment-seeking men and women with opioid dependence, and may be useful in improving identification, prevention, and treatment efforts for this challenging and growing population.
This course is based upon material published as an NIH Public Access Author Manuscript and is available as an open access article.
This course on gender differences in opioid addiction is designed for social workers, professional counselors, psychologists, nurses, and substance abuse counselors, who do clinical work. This course is appropriate for intermediate and advanced level practitioners who wish to develop their understanding of gender differences in opioid addiction.
Authors: Back, et al.
Learning Objectives: This course will provide the practitioner with detailed information regarding gender differences in opioid addiction. Specifically, a professional will:
- Describe gender differences in the clinical profiles of opioid dependent individuals with regard to severity.
- Identify gender differences in the medical conditions of opioid dependent individuals.
- Recognize gender differences in sociological difficulties experienced by opioid dependent individuals.
Citation: Back, S.E., Payne, R., Wahlquist, A., Carter, R., Stroud, Z., Haynes, L., Hillhouse, M., Brady, K. and Ling, W. (2011). Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness
trial. American Journal of Drug Alcohol Abuse, 37(5): 313–323 Reviewed by TM DiDona, PhD 2018 and found to be current. For a full list of current references, please Click Here